Preface to Special Issue: Cancer epidemiology, risk factors and screening

下载PDF

导出

摘要 Cancer continues to be one of the leading causes of morbidity and mortality worldwide, posing significant challenges to public health systems. The International Agency for Research on Cancer(IARC) revealed an increase in the global cancer burden, with 19.3 million new cases and 10 million deaths in 2020 alone(1).

作者 Binghe Xu Hangcheng Xu

机构地区 Department of Medical Oncology

出处《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2023年第6期563-564,共2页 中国癌症研究（英文版）

关键词 CANCER EPIDEMIOLOGY MORTALITY

分类号 R730 [医药卫生—肿瘤] R181.3 [医药卫生—流行病学]

引文网络
相关文献

参考文献5

1无,Jiafu Ji,Zhaode Bu,Jiahui Chen.National guidelines for diagnosis and treatment of gastric cancer 2022 in China(English version)[J].Chinese Journal of Cancer Research,2022,34(3):207-237. 被引量：7
2无,Xinguang Wang,Xue Chen,Dongfeng Niu,Yang Yang,Jingyi Zhao.National guidelines for diagnosis and treatment of breast cancer 2022 in China(English version)[J].Chinese Journal of Cancer Research,2022,34(3):151-175. 被引量：8
3无,Nan Wu,Jia Wang,Quanne Wang.National guidelines for diagnosis and treatment of lung cancer 2022 in China(English version)[J].Chinese Journal of Cancer Research,2022,34(3):176-206. 被引量：5
4National Health Commission of the People’s Republic of China.National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China(English version)[J].Chinese Journal of Cancer Research,2022,34(4):309-334. 被引量：30
5Rongshou Zheng,Siwei Zhang,Hongmei Zeng,Shaoming Wang,Kexin Sun,Ru Chen,Li Li,Wenqiang Wei,Jie He.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9. 被引量：199

共引文献244

1陆玲玲,陈海珍,徐红,朱健,蔡波,陈建国.451例胆囊癌住院患者生存率分析[J].肿瘤,2023,43(9):720-728.
2贺明,丁贤彬,陶然,梁艳,骆致,马周俊,汤成.2011—2021年重庆市九龙坡区结直肠癌疾病负担趋势分析[J].慢性病学杂志,2024(1):1-6.
3郭欣煜,王菲叶,许云,龚璐天,付力,曾钰梅,杨宇飞.病证结合模式下结直肠癌动物模型构建的思考[J].世界科学技术-中医药现代化,2024,26(5):1290-1297.
4黄婉婷,郭涛,张晶,夏勇,沈锋.原发性肝癌气滞血瘀证的研究进展[J].世界科学技术-中医药现代化,2023,25(11):3724-3727. 被引量：2
5汪显超,李娜,黄静,史培峥,钟晓敏,张新江,王哈林,魏小勇,肖珊珊,叶小卫,杨巧红.胃癌患者中医证型与发病节气的相关性研究[J].世界科学技术-中医药现代化,2023,25(10):3384-3393. 被引量：3
6汤欢,夏红,刘芳,苏坚,苏波,苏琦.siRNA沉默DJ-1通过PTEN/Akt通路对人胃癌细胞影响机制[J].中华肿瘤防治杂志,2024,31(13):807-817.
7王萍,孙秀杰,吕云鹏.乳腺癌术后患者重返工作准备度影响因素及中介效应分析[J].黑龙江中医药,2024,53(1):97-100.
8Liyuan Liu,Yong He,Chunyu Kao,Yeye Fan,Fu Yang,Fei Wang,Lixiang Yu,Fei Zhou,Yujuan Xiang,Shuya Huang,Chao Zheng,Han Cai,Heling Bao,Liwen Fang,Linhong Wang,Zengjing Chen,Zhigang Yu.An advanced machine learning method for simultaneous breast cancer risk prediction and risk ranking in Chinese population:A prospective cohort and modeling study[J].Chinese Medical Journal,2024,137(17):2084-2091.
9Yueyang Zhou,Kai Song,Yuqing Chen,Yuelun Zhang,Min Dai,Dong Wu,Hongda Chen.Burden of six major types of digestive system cancers globally and in China[J].Chinese Medical Journal,2024,137(16):1957-1964.
10Wei Cao,Kang Qin,Feng Li,Wanqing Chen.Socioeconomic inequalities in cancer incidence and mortality:An analysis of GLOBOCAN 2022[J].Chinese Medical Journal,2024,137(12):1407-1413. 被引量：2

1John Bukasa-Kakamba,Ayrton I Bangolo,Pascal Bayauli,Branly Mbunga,Francis Iyese,Aliocha Nkodila,Ali Atoot,Gaurav Anand,Stacy H Lee,Maimona Chaudhary,Pamela Q Fernandes,Hari PSS Mannam,Adithya Polavarapu,Merajunissa Merajunnissa,Abdullah Azhar,Mohan N Alichetty,Gauravdeep Singh,Georgemar V Arana Jr,Imranjot Sekhon,Manbir Singh,JoséD Rodriguez-Castro,Adam Atoot,Simcha Weissman,Jean Rene M’buyamba.Proportion of thyroid cancer and other cancers in the democratic republic of Congo[J].World Journal of Experimental Medicine,2023,13(3):17-27.
2Lin Shen.Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges[J].The Innovation,2022,3(3):1-2. 被引量：1
3Agastya Patel,Piotr Spychalski,Magdalena Antoszewska,Jaroslaw Regula,Jarek Kobiela.Proton pump inhibitors and colorectal cancer:A systematic review[J].World Journal of Gastroenterology,2021,27(44):7716-7733. 被引量：1
4Qi Wang,Xiaoju Zhang,Dawei Yang,Li Bai,Chunxue Bai.Criteria for lung cancer screening and standardized management in China[J].Chinese Medical Journal,2023,136(14):1639-1641. 被引量：2
5Maomao Cao,He Li,Dianqin Sun,Siyi He,Xinxin Yan,Fan Yang,Shaoli Zhang,Changfa Xia,Lin Lei,Ji Peng,Wanqing Chen.Current cancer burden in China: epidemiology, etiology, and prevention[J].Cancer Biology & Medicine,2022,19(8):1121-1138. 被引量：72
6Yi Teng,Changfa Xia,Maomao Cao,Fan Yang,Xinxin Yan,Siyi He,Mengdi Cao,Shaoli Zhang,Qianru Li,Nuopei Tan,Jiachen Wang,Wanqing Chen.Lung cancer burden and trends from 2000 to 2018 in China:Comparison between China and the United States[J].Chinese Journal of Cancer Research,2023,35(6):618-626. 被引量：1
7Gregory Marshall,Jian Cao.Mechanism-directed combinational immunotherapies in liver cancer hold promise[J].Cellular & Molecular Immunology,2023,20(11):1395-1397.
8Zhen Tian,Fei Fan,Minglie Hu,Weiwei Liu.Editorial of special issue on OISE major jointly established by Tianjin University and Nankai University[J].Chinese Optics Letters,2023,21(11):1-2.
9Call for Papers——Feature Topic Vol.22,No.3,2025 Special Issue of China Communications:Convergence of 6G empowered Edge Intelligence and Generative AI:Theories,Algorithms,and Applications[J].China Communications,2024,21(1).
10Guangwei Hu,Junsuk Rho.Special issue on digital and intelligent optics[J].Opto-Electronic Science,2023,2(11):1-3.

Chinese Journal of Cancer Research

2023年第6期

浏览历史

内容加载中请稍等...

Preface to Special Issue: Cancer epidemiology, risk factors and screening

参考文献5

共引文献244

相关作者

相关机构

相关主题

浏览历史